[HTML][HTML] Metabolic syndrome and psoriasis: mechanisms and future directions
Y Hao, Y Zhu, S Zou, P Zhou, Y Hu, Q Zhao… - Frontiers in …, 2021 - frontiersin.org
Psoriasis is an immune-mediated systemic disease with associated comorbidities, including
metabolic syndrome (MetS) which contributes substantially to premature mortality in patients …
metabolic syndrome (MetS) which contributes substantially to premature mortality in patients …
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
JJ Wu, A Kavanaugh, MG Lebwohl… - Journal of the …, 2022 - Wiley Online Library
Psoriasis is a chronic systemic inflammatory disorder associated with several comorbidities
in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent …
in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent …
Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders
Metabolic disorders are increasingly prevalent worldwide, leading to high rates of morbidity
and mortality. The variety of metabolic illnesses can be addressed through personalized …
and mortality. The variety of metabolic illnesses can be addressed through personalized …
[HTML][HTML] Inflammation and psoriasis: a comprehensive review
AM Man, MS Orăsan, OA Hoteiuc… - International Journal of …, 2023 - mdpi.com
Psoriasis is an immune-mediated disease with a strong genetic component that brings many
challenges to sick individuals, such as chronic illness, and which has multiple associated …
challenges to sick individuals, such as chronic illness, and which has multiple associated …
The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
A Egeberg, P Gisondi, JM Carrascosa… - Journal of the …, 2020 - Wiley Online Library
Alterations in the innate and adaptive immunity underpin psoriasis pathophysiology, with the
Th17 cells subset now recognized as the fundamental cells in the key controlling pathway …
Th17 cells subset now recognized as the fundamental cells in the key controlling pathway …
[HTML][HTML] Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark
Background Recent studies have indicated an association of gut microbiota and microbial
metabolites with type 2 diabetes mellitus (T2D). However, large-scale investigation of the gut …
metabolites with type 2 diabetes mellitus (T2D). However, large-scale investigation of the gut …
Associations of bifenthrin exposure with glucose homeostasis and type 2 diabetes mellitus in a general Chinese population: Roles of protein carbonylation
R Liang, L Yu, W Liu, C Dong, Q Tan, M Wang… - Environmental …, 2022 - Elsevier
The adverse health effects of pyrethroids exposure have attracted wide concern. We aimed
to assess the associations of bifenthrin, a widely used pyrethroid, with glucose homeostasis …
to assess the associations of bifenthrin, a widely used pyrethroid, with glucose homeostasis …
[HTML][HTML] Increased adipose tissue expression of IL-23 associates with inflammatory markers in people with high LDL cholesterol
Chronic low-grade inflammation induced by obesity is a central risk factor for the
development of metabolic syndrome. High low-density lipoprotein cholesterol (LDL-c) …
development of metabolic syndrome. High low-density lipoprotein cholesterol (LDL-c) …
Viral infection and host immune response in diabetes
G Joshi, A Das, G Verma, P Guchhait - IUBMB life, 2024 - Wiley Online Library
Diabetes, a chronic metabolic disorder disrupting blood sugar regulation, has emerged as a
prominent silent pandemic. Uncontrolled diabetes predisposes an individual to develop fatal …
prominent silent pandemic. Uncontrolled diabetes predisposes an individual to develop fatal …
Shared metabolic and neuroimmune mechanisms underlying type 2 diabetes mellitus and major depressive disorder
E Duarte-Silva, MG de Melo, M Maes… - Progress in Neuro …, 2021 - Elsevier
Abstract Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease with symptoms that
go beyond the domain of glucose metabolism. In fact, research has shown that T2DM is …
go beyond the domain of glucose metabolism. In fact, research has shown that T2DM is …